| Weight | 1 lbs | 
|---|---|
| Dimensions | 9 × 5 × 2 in | 
| host | rabbit  | 
		
| isotype | IgG  | 
		
| clonality | polyclonal  | 
		
| concentration | 1 mg/mL  | 
		
| applications | ICC/IF, WB  | 
		
| reactivity | Bnip3L (IN)  | 
		
| available sizes | 100 µg  | 
		
rabbit anti-Bnip3L (IN) polyclonal antibody 5958
$445.00
Antibody summary
- Rabbit polyclonal to Bnip3L (IN)
 - Suitable for: ELISA,WB,IHC-P,IF
 - Isotype: IgG
 - 100 µg
 
rabbit anti-Bnip3L (IN) polyclonal antibody 5958
| antibody | 
|---|
| Tested applications WB,IHC,IHC,ICC/IF,ELISA  | 
| Recommended dilutions Immunoblotting: use at 1ug/mL. Immunohistochemistry: use at 2ug/mL. These are recommended concentrations. Enduser should determine optimal concentrations for their applications. Positive control: Whole cell lysate of human K562 cells.  | 
| Immunogen Peptide corresponding to aa 77- 92 of human Bnip3L (accession no. AF067396) This amino acid sequence is identical to that of mouse.  | 
| Size and concentration 100µg and lot specific  | 
| Form liquid  | 
| Storage Instructions This antibody is stable for at least one (1) year at -20°C. Avoid multiple freeze-thaw cycles.  | 
| Storage buffer PBS, pH 7.4.  | 
| Purity peptide affinity purification  | 
| Clonality polyclonal  | 
| Isotype IgG  | 
| Compatible secondaries goat anti-rabbit IgG, H&L chain specific, peroxidase conjugated, conjugated polyclonal antibody 9512 goat anti-rabbit IgG, H&L chain specific, biotin conjugated polyclonal antibody 2079 goat anti-rabbit IgG, H&L chain specific, FITC conjugated polyclonal antibody 7863 goat anti-rabbit IgG, H&L chain specific, Cross Absorbed polyclonal antibody 2371 goat anti-rabbit IgG, H&L chain specific, biotin conjugated polyclonal antibody, crossabsorbed 1715 goat anti-rabbit IgG, H&L chain specific, FITC conjugated polyclonal antibody, crossabsorbed 1720  | 
| Isotype control Rabbit polyclonal - Isotype Control  | 
| target relevance | 
|---|
| Protein names BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like (Adenovirus E1B19K-binding protein B5) (BCL2/adenovirus E1B 19 kDa protein-interacting protein 3A) (NIP3-like protein X) (NIP3L)  | 
| Gene names BNIP3L,BNIP3L BNIP3A BNIP3H NIX  | 
| Protein family NIP3 family  | 
| Mass 23930Da  | 
| Function FUNCTION: Induces apoptosis. Interacts with viral and cellular anti-apoptosis proteins. Can overcome the suppressors BCL-2 and BCL-XL, although high levels of BCL-XL expression will inhibit apoptosis. Inhibits apoptosis induced by BNIP3. Involved in mitochondrial quality control via its interaction with SPATA18/MIEAP: in response to mitochondrial damage, participates in mitochondrial protein catabolic process (also named MALM) leading to the degradation of damaged proteins inside mitochondria. The physical interaction of SPATA18/MIEAP, BNIP3 and BNIP3L/NIX at the mitochondrial outer membrane regulates the opening of a pore in the mitochondrial double membrane in order to mediate the translocation of lysosomal proteins from the cytoplasm to the mitochondrial matrix. May function as a tumor suppressor. {ECO:0000269|PubMed:10381623, ECO:0000269|PubMed:21264228}.  | 
| Subellular location SUBCELLULAR LOCATION: Nucleus envelope. Endoplasmic reticulum. Mitochondrion outer membrane. Membrane {ECO:0000305}; Single-pass membrane protein {ECO:0000305}. Note=Colocalizes with SPATA18 at the mitochondrion outer membrane.  | 
| Structure SUBUNIT: Self-associates. Interacts with BNIP3 and STEAP3. Interacts (via BH3 domain) with SPATA18 (via coiled-coil domains). Interacts with PPTC7; this interaction promotes BNIP3L degradation (PubMed:38992176). {ECO:0000269|PubMed:10381623, ECO:0000269|PubMed:12606722, ECO:0000269|PubMed:21264228, ECO:0000269|PubMed:38992176}.; SUBUNIT: (Microbial infection) Interacts with human adenovirus-2 E1B 19 kDa protein. {ECO:0000269|PubMed:10381623}.; SUBUNIT: (Microbial infection) Interacts with Kaposi's sarcoma-associated herpesvirus protein VIRF-1. {ECO:0000269|PubMed:31324791}.  | 
| Post-translational modification PTM: Undergoes progressive proteolysis to an 11 kDa C-terminal fragment, which is blocked by the proteasome inhibitor lactacystin.  | 
| Target Relevance information above includes information from UniProt accession: O60238 | 
| The UniProt Consortium | 
Data
Publications
| pmid | title | authors | citation | 
|---|---|---|---|
| We haven't added any publications to our database yet. | |||
Protocols
| relevant to this product | 
|---|
| Western blot IHC ICC  | 
Documents
| # | SDS | Certificate | |
|---|---|---|---|
| Please enter your product and batch number here to retrieve product datasheet, SDS, and QC information. | |||
Only logged in customers who have purchased this product may leave a review.













Reviews
There are no reviews yet.